Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(25%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
2
25%
Ph not_applicable
4
50%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Not yet recruiting2
Active, not recruiting2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (33.3%)
N/A4 (66.7%)

Trials by Status

unknown225%
completed113%
not_yet_recruiting225%
active_not_recruiting225%
terminated113%

Recent Activity

2 active trials
Showing 5 of 8
active_not_recruitingphase_2

Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

NCT03654131
not_yet_recruitingnot_applicable

MWA With or Without Furmonertinib for Early-Stage Non-Small Cell Lung Cancer

NCT06969781
not_yet_recruitingnot_applicable

Comparing BTVA and MWA in COPD With Early Lung Cancer: Efficacy and Safety

NCT06929390
active_not_recruiting

The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study

NCT06096896
completedphase_2

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

NCT02851784
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03654131Phase 2

Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

Active Not Recruiting
NCT06969781Not Applicable

MWA With or Without Furmonertinib for Early-Stage Non-Small Cell Lung Cancer

Not Yet Recruiting
NCT06929390Not Applicable

Comparing BTVA and MWA in COPD With Early Lung Cancer: Efficacy and Safety

Not Yet Recruiting
NCT06096896

The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study

Active Not Recruiting
NCT02851784Phase 2

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

Completed
NCT04005157Not Applicable

ENB Guided MWA for Early-stage Peripheral Lung Cancer

Unknown
NCT03277716Not Applicable

Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma Huge

Unknown
NCT02787954

Prospective Tumor Response Evaluation

Terminated

All 8 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
8